Physician profile
Jade Cerda
NPI 1982209730
$1,704.16
in general payments reported to CMS, 2019-2025
16 companies · $851 in 2025
The $851 reported for 2025 was more than what 83% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $853 · 2025: $851.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,704.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,704.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $281.05 | 2024-2025 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals Lp | $193.67 | 2024-2025 | Airsupra |
| Amgen INC. | $190.83 | 2025 | Evenity, Prolia |
| Inspire Medical Systems, INC. | $176.27 | 2024 | Inspire |
| Insulet Corporation | $156.29 | 2025 | Omnipod, Omnipod |
| Novo Nordisk INC | $138.04 | 2025 | Ozempic |
| Genzyme Corporation | $132.56 | 2024-2025 | |
| Alkermes, INC. | $103.61 | 2024 | Vivitrol |
| Regeneron Healthcare Solutions, INC. | $102.25 | 2024 | Dupixent |
| Exact Sciences Corporation | $59.98 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Stryker Corporation | $51.66 | 2024 | N/A |
| Hartmann USA, INC. | $34.62 | 2025 | Colactive Plus 2x2, Zetuvit Plus 10x10 P10 |
| Mylan Specialty L.P. | $26.79 | 2024 | Yupelri |
| Aerin Medical INC. | $22.31 | 2024 | |
| Medtronic, INC. | $17.54 | 2024 | Fusion |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $16.69 | 2024 | Gattex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jade Cerda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.